Caroline Downey

When Silicon Valley startups promote polygenic screening and pre-implantation genetic selection as the future of family planning, consumer medicine moves into dangerous transhumanist territory. Caroline Downey breaks down the moral and ethical implications of Silicon Valley tech firms pushing embryo screening to select for non-disease traits like higher IQ, height, and cosmetic features. Unpacking the steep moral price of the commercial IVF industry, Caroline exposes how commodifying human life and treating embryos as customizable consumer products risks sacrificing unselected human embryos while fostering a dystopian eugenic mindset. What does the rise of designer babies reveal about tech-elite hubris, the erosion of respect for human dignity, and the urgent need to halt commercial bio-engineering before it reshapes the human species? Watch Caroline’s full analysis, leave your thoughts below, and subscribe to National Review!